Dosing and Delivery of a Recombinant Surfactant in Lung-injured Adult Sheep
- 1 March 1999
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 159 (3) , 741-747
- https://doi.org/10.1164/ajrccm.159.3.9806069
Abstract
The purpose of this study was to evaluate a surfactant based on a recombinant surfactant protein-C (rSP-C) at three different doses (25, 100, and 200 mg lipid/kg) in the saline lavage adult sheep model of acute lung injury. All three doses resulted in significant improvements in gas exchange, although the 100 and 200 mg/kg doses were superior to the 25 mg/kg dose. There were no significant differences in effect of the 100 and 200 mg/kg doses. In addition, the physiologic efficacy and lobar surfactant distribution patterns were similar when two different surfactant delivery methods were compared. This comparison involved administering the surfactant directly into each lobe under bronchoscopic guidance, versus instilling the surfactant through an endotracheal tube into the lungs. However, the former technique took significantly longer to perform (24.5 +/- 3.3 min versus 11.6 +/- 2.5 min, p < 0.05) and required a skilled bronchoscopist. In conclusion, rSP-C surfactant was effective in improving gas exchange in this model of lung injury, although higher doses were required for optimal responses. The bronchoscopic administration technique produced results similar to those of the tracheal instillation method, but had some disadvantages that may limit the widespread clinical use of this technique in patients with lung injury.Keywords
This publication has 19 references indexed in Scilit:
- Lung Function in Premature Lambs and Rabbits Treated with a Recombinant SP-C SurfactantAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis.American Journal of Respiratory and Critical Care Medicine, 1996
- Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress SyndromeNew England Journal of Medicine, 1996
- Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1995
- Effects of Lung Surfactant Factor (LSF) Treatment on Gas Exchange and Histopathological Changes in an Animal Model of Adult Respiratory Distress Syndrome (ARDS): Comparison of Recombinant LSF with Bovine LSFPulmonary Pharmacology, 1994
- Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep.American Journal of Respiratory and Critical Care Medicine, 1994
- Distribution of Exogenous Surfactant in Rabbits with Severe Respiratory Failure: The Effect of VolumePediatric Research, 1993
- Effect of Volume and Dose on the Pulmonary Distribution of Exogenous Surfactant Administered to Normal Rabbits or to Rabbits with Oleic Acid Lung InjuryAmerican Review of Respiratory Disease, 1990
- Biophysical inhibition of synthetic lung surfactantsChemistry and Physics of Lipids, 1990
- A biophysical mechanism by which plasma proteins inhibit lung surfactant activityChemistry and Physics of Lipids, 1988